The speed of medicine has changed. Healthcare professionals are no longer waiting for conferences or clinical guidelines to make key decisions. In fast-paced clinical settings, physicians are actively ...
Zygomatic implants represent one of the most significant advances in treatment options for seniors with severe maxillary bone loss.
CRISPR Therapeutics reports promising Phase 1 clinical data for CTX310™, with significant triglyceride and LDL reductions, and updates on other programs. CRISPR Therapeutics announced promising new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results